Otomagnetics, Inc.
- UEI
- FB3GPMNB9NE7
- CAGE
- 6VRJ6
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Drug delivery system to save hearing during pediatric chemotherapy regimens | National Cancer Institute (NIH) | $2,299,786 |
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Topical middle ear drug delivery without tympanic membrane puncture | National Institute of Allergy and Infectious Diseases (NIH) | $225,792 |
Quick answers
Is Otomagnetics, Inc. registered in SAM.gov?
Otomagnetics, Inc.'s SAM.gov registration expired on April 29, 2023.
What is Otomagnetics, Inc.'s most recent federal award?
Otomagnetics, Inc.'s most recent federal contract award is Drug delivery system to save hearing during pediatric chemotherapy regimens (HHSN261201700023C), from National Cancer Institute (NIH), on September 19, 2017.
On GovTribe
See Otomagnetics, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors